Emmy Noether Group Leader
University Hospital Würzburg
Würzburg, Bayern, Germany
Dr. Zoltan Nagy has led an independent research group at the Institute of Experimental Biomedicine, University Hospital Würzburg in Germany since 2023. His laboratory is dedicated to uncovering phosphorylation-dependent signal transduction pathways that are crucial for regulating megakaryocyte development and platelet biogenesis. Utilizing a multidisciplinary approach that includes biochemical analytical methods, single-cell RNA sequencing, and transgenic mouse models, Dr. Nagy's group focuses on elucidating the molecular mechanisms underlying megakaryocyte differentiation, maturation, signalling, and platelet production. Dr. Nagy’s research is supported by the Emmy Noether Program of the German Research Foundation (DFG) and could lead to a better understanding of clinical conditions such as thrombocytopenia and myelofibrosis.
Dr. Nagy completed his PhD under the supervision of Dr. Albert Smolenski in Dublin, Ireland, and his postdoctoral training with Prof. Yotis Senis in Birmingham, UK, focusing on the role of kinases and phosphatases in platelet signaling. Subsequently, he joined the institute of Prof. Bernhard Nieswandt in Würzburg, Germany, where he had the opportunity to develop his independent research program on megakaryocytes.
Monday, June 24, 2024
15:30 – 15:45 ICT
OC 78.5 - G6b-B controls transcription factor expression during megakaryocyte maturation
Wednesday, June 26, 2024
11:15 – 11:30 ICT